Cel-Sci Corporation (CVM), a clinical-stage biotechnology company, is capturing the attention of astute investors with its ambitious potential upside of 9,737.05%. Headquartered in Vienna, Virginia, Cel-Sci stands at the forefront..
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) is a trailblazer in the biotechnology sector, offering innovative solutions through its platform for cell programming. Despite facing a challenging financial landscape, the company’s..
Tilray Brands, Inc. (NASDAQ: TLRY), a key player in the healthcare sector, specializes in the cultivation and distribution of medical cannabis products globally. With its market capitalization standing at $424.15..
Kamada Ltd. (NASDAQ: KMDA), a notable player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, has been turning heads with its impressive growth potential. Headquartered..
Intellia Therapeutics, Inc. (NASDAQ: NTLA) commands attention in the biotechnology sector, driven by its pioneering work in gene editing. The company is carving a niche in developing curative genome editing..
Regulus Therapeutics Inc. (NASDAQ: RGLS), a specialist in biotechnology, is sailing through the dynamic waters of the healthcare sector with its innovative focus on microRNA-targeted therapies. Headquartered in San Diego,..
SIGA Technologies Inc. (NASDAQ: SIGA) stands as an intriguing player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With its headquarters in New York, the..
Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is making waves in the healthcare sector with its impressive portfolio of treatments targeting rare diseases. Based out of Deer Park, Illinois, Eton focuses on..
Butterfly Network, Inc. (NASDAQ: BFLY), a healthcare company operating in the medical devices industry, has captured the attention of investors with its innovative approach to ultrasound imaging solutions. Based in..
Prothena Corporation plc (PRTA), a prominent player in the biotechnology sector, has been making waves with its innovative approach to treating diseases caused by protein dysregulation. Based in Dublin, Ireland,..
Cullinan Therapeutics, Inc. (NASDAQ: CGEM) stands out in the biotechnology sector with its focus on developing therapies for autoimmune diseases and cancer. Headquartered in Cambridge, Massachusetts, this clinical-stage biopharmaceutical firm..
For investors with an eye on the biotechnology sector, MBX Biosciences, Inc. (MBX) offers a compelling narrative marked by innovation and substantial potential upside. This clinical-stage biopharmaceutical company is at..
Personalis, Inc. (NASDAQ: PSNL), a leading player in the diagnostics and research sector, is catching the attention of investors with its potential upside of 9.89%. Specializing in advanced cancer genomic..
Arvinas, Inc. (NASDAQ: ARVN) stands as a compelling prospect in the biotechnology sector, driven by its innovative approach to targeting disease-causing proteins. As a clinical-stage company, Arvinas is at the..
COMPASS Pathways Plc (NASDAQ: CMPS), a pioneering biotechnology firm, is at the forefront of developing innovative mental health treatments. With its operations spanning the United Kingdom and the United States,..
Claritev Corporation (NYSE: CTEV) stands out in the health information services sector with its innovative approach to data analytics and technology-enabled cost management. Headquartered in New York, this company has..
Enliven Therapeutics, Inc. (NASDAQ: ELVN), a clinical-stage biopharmaceutical company, offers a captivating opportunity for investors looking to tap into the burgeoning biotechnology sector. With a market capitalization of $1.27 billion..
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a burgeoning player in the biotechnology sector, has captured the attention of investors with its focus on innovative treatments for neurodegenerative diseases. As a clinical-stage..
Orthofix Medical Inc. (NASDAQ: OFIX) presents a compelling case for investors seeking opportunities in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $432.56 million,..
Investors with an eye for biotechnology opportunities may find Precigen, Inc. (NASDAQ: PGEN) an intriguing prospect. With a market cap of $422.11 million, Precigen is positioned within the healthcare sector,..
